Deep neuromuscular block
ApprovedCompleted 0 watching 0 views this week๐ฅ Hot
85
Development Stage
โ
Pre-clinicalโ
Phase 1โ
Phase 2โ
Phase 35
ApprovedIndication / Disease
Surgical Conditions
Conditions
Surgical Conditions
Trial Timeline
Jun 14, 2017 โ Jun 1, 2020
NCT ID
NCT03170661About Deep neuromuscular block
Deep neuromuscular block is a approved stage product being developed by Merck for Surgical Conditions. The current trial status is completed. This product is registered under clinical trial identifier NCT03170661. Target conditions include Surgical Conditions.
Hype Score Breakdown
Clinical
30
Activity
20
Company
10
Novelty
10
Community
12
Clinical Trials (2)
| NCT ID | Phase | Status |
|---|---|---|
| NCT03170661 | Approved | Completed |
| NCT03174223 | Pre-clinical | Completed |
Competing Products
20 competing products in Surgical Conditions